Abstract:Objective To retrospectively analyze the anesthetic management of infant and young child liver transplanta-tion. Methods Seven pediatric patients (including 1 cases of living donor liver transplantation ) with liver transplantation due to congenital biliary atresia and end-stage liver disease in our hospital from July 21,2013 to May 20,2014 were included in this ret-rospective study. The patients entered into the operation room without venous access. The peripheral vein was opened after intra-muscular injection of ketamine 2-5 mg/kg and atropine 0.02 mg/kg. Anesthesia were rapidly induced by intravenous midazolam 0.05-0.20 mg/kg,propofol 2-3 mg/kg,vecuronium 0.1-0.2 mg/kg and fentanyl 5μg/kg. Then intubation was visually performed through mouth. The anesthetic maintenance adopted 2%-3% sevoflurance inhalation combined with 0.2-0.3 μg/(kg·min) remifentanil and 2-3μg/(kg·min)cis-atracurium by venous pump. The indexes including general situation,operation time,time of anhepatic phase,amount of bleeding,urine volume and intravenous infusion amount were observed;the changes of respiration, circulation,blood gas and coagulation indicators were recorded immediately before occlusion of the portal vein ,immediately after occlusion of the portal vein,20 min during the anhepatic phase,immediately after reperfusion,1 h during the neohepatic phase and end of operation. Results All of the seven patients were successfully extubated without obvious anesthesia related compli-cations. HR immediately after occlusion of the portal vein was significantly increased compared with that immediately before oc clusion,and the difference was statistically significant[(129.00±4.38)bpm/min vs. (114.14±11.65)bpm/min,P<0.05],but MAP and CVP at these two time points had no statistically significant (P>0.05);MAP immediately before occlusion of the portal vein and at 1 h during the neohepatic phase were[(45.14±6.49),(54.57±6.50)mm Hg(1 mm Hg=0.133 kPa),which were significantly de-creased compared with(69.57±5.97)mm Hg before occlusion,the differences were statistically signioficant(P<0.05),but HR and CVP had no statistical differences among these 3 time points(P>0.05);blood sodium level at the end of operation was significantly increased compared with that immediately before occlusion[(139.5±3.51)mmol/L vs.(133.00±6.03)mmol/L],blood glucose levels immediately after reperfusion and at 1 h during the neohepatic phase were (11.21±3.90)mmol/L and(13.91±4.48)mmol/L respec-tively,which were significantly higher than(6.39±2.45)mmol/L immediately before occlusion,the differences were statistically significant(P<0.05);the lactic acid level at 1 h during the neohepatic phase was significantly increased compared with that imme-diately before occlusion[(4.40±1.54)mmol/L vs. 2.50±2.16)mmol/L],blood pH value was significantly decreased(7.32±0.04 vs. 7.40±0.07),the difference was statistically significant(P<0.05). Conclusion Anesthesia in infant and young child liver transplan-tation is more elaborate and special. Respiration ,circulation and internal environment should be closely monitored in order to con-duct timely intervention and actively improve the prognosis of infant and young child liver transplantation.

Advance in anesthetics on protecting against hepatic ischemia and reperfusion injury during perioperative period

Protective Effects of Verapamil on Ischemic Precondition for Resection of Liver

Protective Effects of Volatile Anesthetics on Organ Ischemia-Reperfusion Injury

The Role of Plateletactivating Factor in Hepatic Ischemiareperfusion Injury and the Protective Effect of Anisodamine

Preconditioning and Postconditioning Reduce Hepatic Ischemia-Reperfusion Injury in Rats

Selection and rational use of analgesics in perioperative period of liver transplantation

Advances in the Mechanism and Prevention of Liver Ischemia Reperfusion Injury

Liver protection in the perioperative setting

A Review of Anesthetic Effects on Renal Function: Potential Organ Protection

Protective Effects of Desflurane Pretreatment in Ischemical Reperfusion Injury of Liver and its Mechanisms

Anesthetic management of infant and young child with liver transplantation

Advances in molecular mechanisms of liver ischemia reperfusion injury

Current Studies on Therapeutic Approaches for Ischemia/reperfusion Injury in Steatotic Livers

Pre‐conditions for Eliminating Mitochondrial Dysfunction and Maintaining Liver Function after Hepatic Ischaemia Reperfusion

Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion

Attenuation of intestinal ischemia-reperfusion-injury by anesthetics: a potentially protective effect of anesthetic management in experimental studies

Advance in Clinicalapplication of Volatile Anesthetic-Induced Myocardial Protection

The Mechanisms and Strategies to Protect from Hepatic Ischemia-Reperfusion Injury.

Anesthetic Management for Liver Re-Transplantation

Melatonin and its protective role in attenuating warm or cold hepatic ischaemia/reperfusion injury

Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury